Merit Medical Systems (MMSI) Set to Release Quarterly Earnings on Thursday

Merit Medical Systems (NASDAQ:MMSI) is anticipated to release its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $1.04 per share and revenue of $410.34 million for the quarter. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Parties may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, October 29, 2026 at 4:30 PM ET.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. The firm had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the previous year, the company posted $1.01 earnings per share. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, analysts expect Merit Medical Systems to post $3.84 EPS for the current fiscal year and $4.17 EPS for the next fiscal year.

Merit Medical Systems Trading Down 0.7%

MMSI opened at $93.53 on Wednesday. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.85. The firm’s fifty day moving average price is $88.60 and its two-hundred day moving average price is $77.09.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on MMSI shares. Piper Sandler increased their price objective on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Bank of America lifted their target price on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. Wells Fargo & Company lifted their target price on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Needham & Company LLC reissued a “buy” rating and issued a $101.00 target price on shares of Merit Medical Systems in a research note on Tuesday, September 29th. Finally, Canaccord Genuity Group upped their target price on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.